Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:00:37 UTC
Update Date2021-09-14 15:46:28 UTC
HMDB IDHMDB0013962
Secondary Accession Numbers
  • HMDB13962
Metabolite Identification
Common NameVerapamil metabolite D-617
DescriptionVerapamil metabolite D-617 belongs to the class of organic compounds known as phenylbutylamines. Phenylbutylamines are compounds containing a phenylbutylamine moiety, which consists of a phenyl group substituted at the fourth carbon by an butan-1-amine. Verapamil metabolite D-617 is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on Verapamil metabolite D-617.
Structure
Data?1582753158
Synonyms
ValueSource
2-(3,4-Dimethoxyphenyl)-5-amino-2-isopropylvaleronitrileChEBI
3,4-Dimethoxy-alpha-(3-(methylamino)propyl)-alpha-(1-methylethyl)benzeneacetonitrileChEBI
3-(3,4-Dimethoxyphenyl)-2-methyl-6-methylaminohexane-3-carbonitrileChEBI
3,4-Dimethoxy-a-(3-(methylamino)propyl)-a-(1-methylethyl)benzeneacetonitrileGenerator
3,4-Dimethoxy-α-(3-(methylamino)propyl)-α-(1-methylethyl)benzeneacetonitrileGenerator
1-Isopropyl-1-N-methylpropylamino-(3,4-dimethoxyphenyl)acetonitrileHMDB
2-(3,4-Dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile hydrochlorideHMDB
Chemical FormulaC17H26N2O2
Average Molecular Weight290.4005
Monoisotopic Molecular Weight290.199428086
IUPAC Name2-(3,4-dimethoxyphenyl)-5-(methylamino)-2-(propan-2-yl)pentanenitrile
Traditional Name2-(3,4-dimethoxyphenyl)-2-isopropyl-5-(methylamino)pentanenitrile
CAS Registry NumberNot Available
SMILES
CNCCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C=C1
InChI Identifier
InChI=1S/C17H26N2O2/c1-13(2)17(12-18,9-6-10-19-3)14-7-8-15(20-4)16(11-14)21-5/h7-8,11,13,19H,6,9-10H2,1-5H3
InChI KeyWLOBUUJURNEQCL-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenylbutylamines. Phenylbutylamines are compounds containing a phenylbutylamine moiety, which consists of a phenyl group substituted at the fourth carbon by an butan-1-amine.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassPhenylbutylamines
Direct ParentPhenylbutylamines
Alternative Parents
Substituents
  • Phenylbutylamine
  • Dimethoxybenzene
  • O-dimethoxybenzene
  • Phenylpropane
  • Phenoxy compound
  • Anisole
  • Methoxybenzene
  • Phenol ether
  • Alkyl aryl ether
  • Aralkylamine
  • Nitrile
  • Carbonitrile
  • Ether
  • Secondary aliphatic amine
  • Secondary amine
  • Organopnictogen compound
  • Organic nitrogen compound
  • Amine
  • Organooxygen compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Organic oxygen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.026 g/LALOGPS
logP3.18ALOGPS
logP2.96ChemAxon
logS-4.1ALOGPS
pKa (Strongest Basic)10.54ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area54.28 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity85.06 m³·mol⁻¹ChemAxon
Polarizability34.06 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+170.76131661259
DarkChem[M-H]-170.78931661259
DeepCCS[M+H]+180.72130932474
DeepCCS[M-H]-178.36330932474
DeepCCS[M-2H]-211.24930932474
DeepCCS[M+Na]+186.81430932474
AllCCS[M+H]+171.532859911
AllCCS[M+H-H2O]+168.332859911
AllCCS[M+NH4]+174.532859911
AllCCS[M+Na]+175.432859911
AllCCS[M-H]-176.132859911
AllCCS[M+Na-2H]-176.832859911
AllCCS[M+HCOO]-177.732859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.4.39 minutes32390414
Predicted by Siyang on May 30, 202211.4182 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.83 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid42.5 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1599.6 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid214.5 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid171.6 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid170.1 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid98.9 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid422.2 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid396.5 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)322.9 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid944.0 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid413.5 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1124.5 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid249.4 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid323.0 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate361.8 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA288.3 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water8.6 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Verapamil metabolite D-617CNCCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C=C12674.7Standard polar33892256
Verapamil metabolite D-617CNCCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C=C12188.8Standard non polar33892256
Verapamil metabolite D-617CNCCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C=C12144.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Verapamil metabolite D-617,1TMS,isomer #1COC1=CC=C(C(C#N)(CCCN(C)[Si](C)(C)C)C(C)C)C=C1OC2253.4Semi standard non polar33892256
Verapamil metabolite D-617,1TMS,isomer #1COC1=CC=C(C(C#N)(CCCN(C)[Si](C)(C)C)C(C)C)C=C1OC2485.3Standard non polar33892256
Verapamil metabolite D-617,1TMS,isomer #1COC1=CC=C(C(C#N)(CCCN(C)[Si](C)(C)C)C(C)C)C=C1OC2977.8Standard polar33892256
Verapamil metabolite D-617,1TBDMS,isomer #1COC1=CC=C(C(C#N)(CCCN(C)[Si](C)(C)C(C)(C)C)C(C)C)C=C1OC2479.0Semi standard non polar33892256
Verapamil metabolite D-617,1TBDMS,isomer #1COC1=CC=C(C(C#N)(CCCN(C)[Si](C)(C)C(C)(C)C)C(C)C)C=C1OC2688.2Standard non polar33892256
Verapamil metabolite D-617,1TBDMS,isomer #1COC1=CC=C(C(C#N)(CCCN(C)[Si](C)(C)C(C)(C)C)C(C)C)C=C1OC3061.9Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Verapamil metabolite D-617 GC-MS (Non-derivatized) - 70eV, Positivesplash10-0006-9260000000-fb2a8a58d074c62ca0152017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Verapamil metabolite D-617 GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-QTOF , positive-QTOFsplash10-0006-0090000000-9e47d8c16d34365daa4f2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-QTOF , positive-QTOFsplash10-0006-0190000000-0d042fbd532e098eda082017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-QTOF , positive-QTOFsplash10-0v00-0950000000-58fff8b2f60d4f9f33602017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-QTOF , positive-QTOFsplash10-0udi-0910000000-5743fe577b05c091365c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-QTOF , positive-QTOFsplash10-0udi-0900000000-991717d07573881d24072017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-01ot-0090000000-2897763a114ddb39d24a2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0006-0090000000-0838f19b1501a753f6662017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0006-0090000000-978c3997fb64a74bd8762017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0j6v-0790000000-78a3aed7c008b2d701fd2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0uxr-0920000000-43775fc36f2ea5b4b1352017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0udi-1910000000-fa97a76832c7994725342017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0uds-1900000000-6fe3e4cdef10f5f4f05c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0006-0090000000-19358fa40738da4edaaa2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0006-0090000000-aa23edcedb7045a6d2502017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0hi7-1790000000-b87e5fc9961f557043ba2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0udi-1920000000-80cf25e099ff99ccc5e72017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0udi-1910000000-f76de07b3c19c41b76772017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-0uka-1900000000-b6b11ba7885764a4d6a42017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Verapamil metabolite D-617 LC-ESI-ITFT , positive-QTOFsplash10-01ot-0090000000-a11aad23192e8843f90c2017-09-14HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Verapamil metabolite D-617 10V, Positive-QTOFsplash10-01ox-0090000000-fa208b0667479c76ba152016-08-02Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Verapamil metabolite D-617 20V, Positive-QTOFsplash10-0234-0090000000-52ba91de3da3169dfa092016-08-02Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Verapamil metabolite D-617 40V, Positive-QTOFsplash10-00r6-2390000000-077c99b1be8d735ab99a2016-08-02Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Verapamil metabolite D-617 10V, Negative-QTOFsplash10-000i-0090000000-5e3a6430e68a8b0b73172016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Verapamil metabolite D-617 20V, Negative-QTOFsplash10-000i-0090000000-cc16417b47098f4203662016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Verapamil metabolite D-617 40V, Negative-QTOFsplash10-0k96-1190000000-d1a1b249aedbb1ba9be72016-08-03Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID84112
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound93168
PDB IDNot Available
ChEBI ID83528
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available